Understanding Endometriosis

Endometriosis is a perplexing and often distressing condition affecting an estimated one in five women during their reproductive years. It occurs when tissue similar to the endometrium — the lining of the uterus — grows in places it should not, such as the ovaries, Fallopian tubes, bladder, bowel, or other areas of the pelvic cavity. In rare cases it has even been found in distant organs including the lungs and skin. As oestrogen rises during the first half of the menstrual cycle, this misplaced tissue responds in the same way as the uterine lining, swelling and bleeding. The result can be pain ranging from mild discomfort to severe, debilitating agony.

Symptoms vary widely between women but commonly include pelvic pain, lower back pain, painful intercourse, painful bowel movements or urination, fatigue, spotting between periods and infertility. For some the symptoms worsen around menstruation, while for others pain can persist throughout the month. Because the disease behaves differently in each woman, diagnosis and treatment can often be frustrating and prolonged.

Although the precise cause remains uncertain, several hormonal patterns are frequently observed. Research indicates that many women with endometriosis produce insufficient progesterone, often with a shortened luteal phase. In some cases the endometrial tissue itself appears resistant to progesterone, meaning the body’s normal levels are not enough to counterbalance the stimulating effects of oestrogen. The condition is therefore considered strongly oestrogen-dependent, with oestrogen promoting the growth and activity of endometrial cells, while progesterone normally acts to inhibit this proliferation.

Progesterone suppresses enzymes known as matrix metalloproteinases (MMPs), which are involved in tissue invasion and lesion formation. When progesterone levels are inadequate, or when tissues become resistant to its action, these enzymes may remain active, allowing displaced endometrial cells to invade surrounding tissue. Environmental toxins such as dioxins have also been shown to interfere with progesterone’s ability to regulate these processes.

Increasing evidence also suggests oxidative stress plays a major role in the development and progression of endometriosis. For this reason antioxidants and nutrients involved in glutathione production — such as N-acetyl cysteine, glycine and glutamine — together with adequate vitamin D levels, are often considered important supportive factors.

Conventional treatment commonly includes anti-inflammatory drugs, hormonal contraceptives, aromatase inhibitors or surgery, all aimed at reducing oestrogen stimulation or removing lesions. Yet because endometriosis is complex and frequently progressive, responses to treatment vary widely. Addressing hormonal balance — particularly the relationship between oestrogen and progesterone — remains a key consideration in understanding and managing this challenging condition.

For more information and reference and research papers visit our pages: Endometriosis FAQ and Endometriosis Symptoms.